See more : Artemis Therapeutics Inc. (ATMS) Income Statement Analysis – Financial Results
Complete financial analysis of Merida Merger Corp. I (MCMJ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Merida Merger Corp. I, a leading company in the Shell Companies industry within the Financial Services sector.
- Revolve Group, Inc. (RVLV) Income Statement Analysis – Financial Results
- Marston’s PLC (MARZF) Income Statement Analysis – Financial Results
- Kalamazoo Resources Limited (KAMRF) Income Statement Analysis – Financial Results
- Monarch Networth Capital Limited (MONARCH.BO) Income Statement Analysis – Financial Results
- ISS A/S (ISS.CO) Income Statement Analysis – Financial Results
Merida Merger Corp. I (MCMJ)
About Merida Merger Corp. I
As of February 4, 2022, Merida Merger Corp. I was acquired by Leafly Holdings, Inc., in a reverse merger transaction. Merida Merger Corp. I does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the cannabis industry. The company was incorporated in 2019 and is based in New York, New York.
Metric | 2020 | 2019 |
---|---|---|
Revenue | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 |
SG&A | 0.00 | 0.00 |
Other Expenses | 661.22K | 167.53K |
Operating Expenses | 661.22K | 167.53K |
Cost & Expenses | 661.22K | 167.53K |
Interest Income | 787.35K | 0.00 |
Interest Expense | 0.00 | 296.02K |
Depreciation & Amortization | 789.41K | 592.03K |
EBITDA | 128.19K | 424.50K |
EBITDA Ratio | 0.00% | 0.00% |
Operating Income | -661.22K | -167.53K |
Operating Income Ratio | 0.00% | 0.00% |
Total Other Income/Expenses | 789.41K | 296.01K |
Income Before Tax | 128.19K | 128.48K |
Income Before Tax Ratio | 0.00% | 0.00% |
Income Tax Expense | 27.11K | 26.98K |
Net Income | 101.08K | 101.50K |
Net Income Ratio | 0.00% | 0.00% |
EPS | 0.01 | 0.01 |
EPS Diluted | 0.01 | 0.01 |
Weighted Avg Shares Out | 16.37M | 16.57M |
Weighted Avg Shares Out (Dil) | 16.37M | 16.57M |
‘This is huge for us': Interview with Leafly CEO as cannabis company goes public in SPAC merger
Leafly shares start trading after acquisition by SPAC Merida Merger
Cannabis marketplace Leafly closes SPAC merger deal and will go public on Monday
Alan Brochstein On Cannabis Investing In 2022 (Video Transcript)
Marijuana Stocks To Keep On Your Radar This Year
Leafly: Expect De-SPAC Pain
Top Ancillary Cannabis Stocks For January 2022
2 New Marijuana Stocks To Add To Your Watchlist In 2022
Leafly Cannabis Info Platform Names New CFO Ahead Of Going Public On Nasdaq
3 Cannabis SPACs Hoping to Get High
Source: https://incomestatements.info
Category: Stock Reports